Breaking News Instant updates and real-time market news.

FOX

21st Century Fox

$24.79

-0.07 (-0.28%)

, FOXA

21st Century Fox

$24.68

-0.05 (-0.20%)

08:42
10/18/16
10/18
08:42
10/18/16
08:42

20th Century Fox invests in VR startup, Fortune reports

Virtual Reality startup Baobab Studios is getting a lot of attention from VR investors and film studios for its VR animated shorts, with the company saying it has landed $25M in a funding round led by Horizons Ventures along with 20th Century Fox, Evolution Media Partners, Shanghai Media Group, Youku Global Media Fund, and LDV Partners, according to Fortune. Reference Link

FOX

21st Century Fox

$24.79

-0.07 (-0.28%)

FOXA

21st Century Fox

$24.68

-0.05 (-0.20%)

  • 02

    Nov

  • 10

    Nov

FOX 21st Century Fox
$24.79

-0.07 (-0.28%)

09/06/16
RHCO
09/06/16
NO CHANGE
Target $18
RHCO
Neutral
SunTrust sees 'limited' list of Twitter suitors, says activist action unlikely
SunTrust analyst Robert Peck reiterated his belief that Twitter (TWTR) is unlikely to sell itself in 2016 in a new note to investors, but noted that investors have asked him who would be interested if Twitter were open to a sale. While giving his opinion on potential acquirers - which he sees possibly including Google (GOOG), Facebook (FB), Apple (AAPL), Amazon (AMZN), Microsoft (MSFT), AT&T (T), Verizon (VZ), Disney (DIS), Fox (FOXA), and Alibaba (BABA) - Peck said the company's high price and "unique" asset limit the potential buyers and gave his view that a PE buyer is highly unlikely given the company's lack of free cash flow. Additionally, Peck thinks activist action at Twitter seems "extremely unlikely" despite "unsubstantiated investor conjecture" and media reports. The analyst keeps Neutral rating and $18 price target on Twitter shares.
09/15/16
BERN
09/15/16
DOWNGRADE
BERN
Market Perform
21st Century Fox downgraded to Market Perform from Outperform at Bernstein
09/16/16
09/16/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. 21st Century Fox (FOX, FOXA) downgraded to Market Perform from Outperform at Bernstein with analyst Jason Park citing a reduction in his estimates for the company's Star India business. 2. Wells Fargo (WFC) downgraded to Underweight from Neutral at Atlantic Equities. 3. Citi (C) downgraded to Neutral from Buy at Goldman with analyst Richard Ramsden saying Citi's expected earnings inflection has failed to materialize and ROEs are at 7.7%, well below management's 10% target. 4. McCormick (MKC) downgraded to Market Perform from Outperform at Bernstein with analyst Alexia Howard citing valuation. 5. Novavax (NVAX) downgraded to Neutral from Overweight at Piper Jaffray, to Neutral from Overweight at JPMorgan, to Neutral from Buy at Ladenburg, to Neutral from Outperform at Wedbush, and to Neutral from Buy at Citi. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/26/16
UBSW
09/26/16
NO CHANGE
Target $92
UBSW
Neutral
Consumer satisfaction with competitors has caught up to Netflix, says UBS
UBS analyst Doug Mitchelson said that the firm's Evidence Lab survey indicated that U.S. consumer satisfaction with Amazon Prime Video (AMZN) and Hulu - the joint venture owned by Time Warner (TWX), Comcast (CMCSA), 21st Century Fox (FOXA), and Disney (DIS) - has now caught up to Netflix (NFLX), advising that investors should "continue to monitor competitive threats closely" as Netflix leads the category but demand for consumer media time, attention and wallet has intensified. The analyst, who added that Netflix's "pricing power remains unclear" based on the firm's survey work, keeps a Neutral rating and $92 price target on Netflix shares.
FOXA 21st Century Fox
$24.68

-0.05 (-0.20%)

09/16/16
BERN
09/16/16
DOWNGRADE
BERN
Market Perform
21st Century Fox downgraded to Market Perform from Outperform at Bernstein
As noted earlier, Bernstein downgraded 21st Century Fox to Market Perform from Outperform. Analyst Jason Park based the downgrade on a reduction in his estimates for the company's Star India business. However, he thinks the company faces many other risks, including lower domestic affiliate fees, lower overseas advertising revenue, and higher cable network expenses. Additionally, he thinks that investors will remain skeptical about the stock even if the company beats his estimates. Target $26.
10/14/16
RBCM
10/14/16
NO CHANGE
RBCM
21st Century Fox setup into results positive, says RBC Capital
RBC Capital analyst Steven Cahall thinks that 21st Century Fox's stock will react positively to its Q1 results despite the weak performance of its films and "mild weakness" in broadcast ratings. If no other problems emerge, the stock can rise, the analyst believes. He thinks that the stock's valuation is attractive

TODAY'S FREE FLY STORIES

INOV

Inovalon

$11.30

-0.45 (-3.83%)

07:01
02/21/17
02/21
07:01
02/21/17
07:01
Recommendations
Inovalon analyst commentary  »

Piper sees lawsuit as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

SRPT

Sarepta

$28.28

0.31 (1.11%)

07:00
02/21/17
02/21
07:00
02/21/17
07:00
Hot Stocks
Sarepta agrees to sale of priority review voucher for $125M »

Sarepta Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 28

    Feb

SEAS

SeaWorld

$19.21

-0.03 (-0.16%)

07:00
02/21/17
02/21
07:00
02/21/17
07:00
Earnings
Breaking Earnings news story on SeaWorld »

SeaWorld reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

TVPT

Travelport

$14.14

-0.06 (-0.42%)

06:58
02/21/17
02/21
06:58
02/21/17
06:58
Earnings
Travelport reports Q4 adjusted EPS 23c, consensus 20c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 01

    Mar

MDT

Medtronic

$78.88

0.89 (1.14%)

06:58
02/21/17
02/21
06:58
02/21/17
06:58
Earnings
Medtronic reports Q3 EPS $1.12, consensus $1.11 »

Reports Q3 revenue $7.3B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 22

    Feb

  • 22

    Feb

  • 27

    Feb

  • 27

    Feb

  • 07

    Mar

  • 17

    Mar

  • 21

    Mar

REXR

Rexford Industrial

$22.92

0.24 (1.06%)

06:57
02/21/17
02/21
06:57
02/21/17
06:57
Hot Stocks
Rexford Industrial acquires industrial property in Los Angeles for $17.1M »

Rexford Industrial Realty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOXO

Loxo Oncology

$41.74

0.36 (0.87%)

06:56
02/21/17
02/21
06:56
02/21/17
06:56
Hot Stocks
Loxo Oncology completes enrollment for larotrectinib NDA »

Loxo Oncology announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$30.37

-0.08 (-0.26%)

06:56
02/21/17
02/21
06:56
02/21/17
06:56
Periodicals
GE succession plan near top of investors' minds, WSJ says »

General Electric CEO Jeff…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 26

    Apr

JELD

JELD-WEN Holding

$29.48

0.48 (1.66%)

06:56
02/21/17
02/21
06:56
02/21/17
06:56
Initiation
JELD-WEN Holding initiated  »

JELD-WEN Holding…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRVN

Trevena

$7.13

0.1 (1.42%)

06:55
02/21/17
02/21
06:55
02/21/17
06:55
Hot Stocks
Breaking Hot Stocks news story on Trevena »

Trevena trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 21

    Mar

TIF

Tiffany

$86.18

3.17 (3.82%)

06:54
02/21/17
02/21
06:54
02/21/17
06:54
Hot Stocks
Tiffany, JANA Partners announce agreement to appoint 3 new independent directors »

Tiffany and JANA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENBL

Enable Midstream

$16.73

0.11 (0.66%)

06:54
02/21/17
02/21
06:54
02/21/17
06:54
Hot Stocks
Breaking Hot Stocks news story on Enable Midstream »

Enable Midstream…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

ENBL

Enable Midstream

$16.73

0.11 (0.66%)

06:53
02/21/17
02/21
06:53
02/21/17
06:53
Earnings
Enable Midstream reports Q4 EPS 14c, consensus 18c »

Reports Q4 revenue $614M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

WLK

Westlake Chemical

$61.66

-0.99 (-1.58%)

06:51
02/21/17
02/21
06:51
02/21/17
06:51
Earnings
Westlake Chemical reports Q4 EPS 76c with items, consensus 80c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

JNCE

Jounce Therapeutics

$19.90

0.24 (1.22%)

06:51
02/21/17
02/21
06:51
02/21/17
06:51
Initiation
Jounce Therapeutics initiated  »

Jounce Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JELD

JELD-WEN Holding

$29.48

0.48 (1.66%)

06:50
02/21/17
02/21
06:50
02/21/17
06:50
Initiation
JELD-WEN Holding initiated  »

JELD-WEN Holding…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EDR

EdR

$40.69

-0.06 (-0.15%)

06:48
02/21/17
02/21
06:48
02/21/17
06:48
Earnings
EdR reaffirms FY17 EPS view 66c-76c, consensus 63c »

Sees FY17 core FFO per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

HURN

Huron

$42.60

-4 (-8.58%)

06:48
02/21/17
02/21
06:48
02/21/17
06:48
Downgrade
Huron rating change  »

Huron downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 28

    Feb

EDR

EdR

$40.69

-0.06 (-0.15%)

06:47
02/21/17
02/21
06:47
02/21/17
06:47
Earnings
EdR reports Q4 EPS 19c, consensus 23c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

MCO

Moody's

$112.90

2.68 (2.43%)

06:45
02/21/17
02/21
06:45
02/21/17
06:45
Downgrade
Moody's rating change  »

Moody's downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 02

    Mar

  • 05

    Mar

RIC

Richmont Mines

$9.30

-0.2 (-2.11%)

06:45
02/21/17
02/21
06:45
02/21/17
06:45
Earnings
Richmont Mines reports Q4 EPS 1c, consensus 4c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

LMOS

Lumos Networks

$15.23

0.09 (0.59%)

, ZAYO

Zayo Group

$30.83

-0.16 (-0.52%)

06:41
02/21/17
02/21
06:41
02/21/17
06:41
Downgrade
Lumos Networks, Zayo Group, GTT Communications rating change  »

Lumos Networks downgraded…

LMOS

Lumos Networks

$15.23

0.09 (0.59%)

ZAYO

Zayo Group

$30.83

-0.16 (-0.52%)

GTT

GTT Communications

$29.00

-0.05 (-0.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AER

AerCap

$46.65

-0.14 (-0.30%)

06:41
02/21/17
02/21
06:41
02/21/17
06:41
Hot Stocks
AerCap approves $350M share repurchase program »

Company authorized a new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGEN

Miragen Therapeutics

$11.80

0.79 (7.18%)

06:40
02/21/17
02/21
06:40
02/21/17
06:40
Initiation
Miragen Therapeutics initiated  »

Miragen Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AER

AerCap

$46.65

-0.14 (-0.30%)

06:40
02/21/17
02/21
06:40
02/21/17
06:40
Hot Stocks
Breaking Hot Stocks news story on AerCap »

AerCap reports Q4 $49.33…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.